You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Smoldering Multiple Myeloma

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gene Expression Profile of Bone Marrow Plasma Cells From MGUS

Terminated
  • Monoclonal Gammopathy of Undetermined Significance
  • Smoldering Myeloma
  • Genetic study of DNA copies
  • Rennes, Bretagne, France
  • +26 more
Apr 13, 2021

Multiple Myeloma Trial in Houston (TAA-specific CTLs, TAA-specific CTLs- fixed dose)

Recruiting
  • Multiple Myeloma
  • TAA-specific CTLs
  • TAA-specific CTLs- fixed dose
  • Houston, Texas
    Houston Methodist Hospital
Nov 11, 2022

Multiple Myeloma Trial (MLN9708, Dexamethasone)

Withdrawn
  • Multiple Myeloma
  • (no location specified)
Dec 13, 2019

Multiple Myeloma, Myeloma, Smoldering Multiple Myeloma Trial run by the NCI ((Anti-KIR))

Terminated
Has Results
  • Multiple Myeloma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 7, 2019

High-risk Smoldering Multiple Myeloma Trial in Worldwide (Siltuximab, Placebo)

Completed
Has Results
  • High-risk Smoldering Multiple Myeloma
  • Chicago, Illinois
  • +39 more
Jan 23, 2020

Smoldering Plasma Cell Myeloma Trial in Duarte (Leflunomide, Quality-of-Life Assessment, Questionnaire Administration)

Withdrawn
  • Smoldering Plasma Cell Myeloma
  • Duarte, California
    City of Hope Medical Center
Nov 12, 2019

Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance Trial (Fluciclatide)

Withdrawn
  • Multiple Myeloma
  • +2 more
  • (no location specified)
Dec 13, 2019

Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma Trial in Boston (Elranatamab)

Not yet recruiting
  • Refractory Multiple Myeloma
  • +2 more
  • Boston, Massachusetts
  • +2 more
Nov 17, 2023

Multiple Myeloma Trial in Tucson (Immediate yoga intervention, Delayed yoga intervention)

Not yet recruiting
  • Multiple Myeloma
  • Immediate yoga intervention
  • Delayed yoga intervention
  • Tucson, Arizona
    University of Arizona Cancer Center
Sep 27, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • (no location specified)
Oct 30, 2023

Multiple Myeloma Trial (AZD0305)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 24, 2023

Asymptomatic Myeloma Trial in New Haven (Atezolizumab (1200mg via IV infusion))

Terminated
  • Asymptomatic Myeloma
  • Atezolizumab (1200mg via IV infusion)
  • New Haven, Connecticut
    Yale University
Feb 28, 2020

Multiple Myeloma Trial (Teclistamab, Tocilizumab)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jul 24, 2023

Clinical Pathways for Newly Diagnosed Multiple Myeloma

Not yet recruiting
  • Multiple Myeloma
  • Multiple Myeloma Without Mention of Remission
  • Multiple Myeloma Pathway
  • +2 more
  • (no location specified)
Nov 27, 2023

Multiple Myeloma Trial (CM313 injection)

Not yet recruiting
  • Multiple Myeloma
  • CM313 injection
  • (no location specified)
Nov 6, 2023

Project in First-degree Relatives of Myeloma Patient - The

Recruiting
  • Multiple Myeloma
  • Monoclonal Gammopathy of Undetermined Significance
  • Sample of Blood
  • Shanghai, Shanghai, China
    Zhongshan Hospital，Fudan University
Jul 31, 2023

Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial run by the

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • 18F-fluciclovine injection
  • 18F-FDG PET/CT
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 31, 2023

Multiple Myeloma Trial in Boston (THRIVE-M)

Not yet recruiting
  • Multiple Myeloma
  • THRIVE-M
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 2, 2023

Relapsed and/or Refractory Multiple Myeloma Trial in Köln (BMS-986453, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • Relapsed and/or Refractory Multiple Myeloma
  • Köln, Germany
    Local Institution - 0017
Dec 4, 2023

Multiple Myeloma Prognostic Indices

Recruiting
  • Multiple Myeloma
  • Hematologic Diseases
  • blood viscosity , albumin / fibrinogen ratio and red cell distribution
  • Assiut, Egypt
    Assiut University hospital
Oct 17, 2023

The Indiana Myeloma Registry

Recruiting
  • Plasma Cell Dyscrasias
  • This is a non-interventional trial
  • Indianapolis, Indiana
    Indiana University Simon Cancer Center
Mar 2, 2022

Multiple Myeloma Trial in Wuhan (Total Marrow irradiation,TMI, Autologous hematopoietic stem cell transplantation)

Recruiting
  • Multiple Myeloma
  • Total Marrow irradiation，TMI
  • Autologous hematopoietic stem cell transplantation
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jul 24, 2023

Multiple Myeloma in Relapse Trial in Shenzhen (BCMA/GPRC5D double CAR-T)

Recruiting
  • Multiple Myeloma in Relapse
  • BCMA/GPRC5D double CAR-T
  • Shenzhen, Guangdong, China
    Shenzhen Qianhai Shekou Free Trade Zone Hospital
Sep 28, 2023

Determine the Optimal Initial Therapy for Multiple Myeloma

Recruiting
  • Multiple Myeloma
  • Non-Interventional Study
  • Scottsdale, Arizona
  • +3 more
Nov 22, 2023

Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Myeloma-Associated Amyloidosis
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 6, 2023